DopamineReceptors, DopamineReceptors, Dopamine D2Receptors, Dopamine D1Dopamine AgonistsDopamine AntagonistsReceptors, Dopamine D3Receptors, Dopamine D5Dopamine AgentsDopamine Plasma Membrane Transport ProteinsQuinpiroleBenzazepinesSpiperoneCorpus StriatumApomorphineDopamine Uptake InhibitorsSalicylamidesSulpirideHaloperidolRacloprideReceptors, Dopamine D4Ergolines2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineDopamine beta-HydroxylaseFlupenthixolNucleus AccumbensNeostriatumButaclamolCocaineAmphetamineLevodopaDomperidoneDopamine and cAMP-Regulated Phosphoprotein 32Rats, Sprague-DawleyBromocriptineCaudate NucleusOxidopamineBehavior, AnimalHomovanillic AcidSubstantia NigraTyrosine 3-MonooxygenaseDopaminergic NeuronsMSH Release-Inhibiting HormoneMotor ActivityNeuronsBrainPergolideVentral Tegmental AreaMicrodialysisPutamenDose-Response Relationship, DrugRadioligand AssayMesencephalonCatalepsyAntipsychotic AgentsDyskinesia, Drug-InducedStereotyped Behavioralpha-MethyltyrosineTetrahydronaphthalenesRewardDihydroxyphenylalaninePyrrolidinesHydroxydopaminesMethamphetamineNomifensineBasal GangliaAntiparkinson AgentsPimozidePrefrontal CortexFenoldopamVesicular Monoamine Transport ProteinsClozapineParkinsonian DisordersBrain ChemistryYawningCentral Nervous System StimulantsReserpineSerotoninSelf AdministrationLisurideTropanesFluphenazineNorepinephrineSynaptic TransmissionConditioning, OperantDextroamphetamineCyclic AMP1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineRats, WistarPhenanthridinesDrug InteractionsAnalysis of VarianceNerve Tissue ProteinsDrug Partial AgonismCatecholaminesParkinson Disease, SecondaryBiogenic MonoaminesBinding, CompetitiveLimbic SystemCocaine-Related Disorders